-
OMGA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Omega Therapeutics (OMGA)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 30.72 mm | 30.72 mm | 30.72 mm | 30.72 mm | 30.72 mm | |
Cash burn (monthly) | 9.89 mm | 6.26 mm | 5.47 mm | 6.71 mm | 4.33 mm | |
Cash used (since last report) | 27.85 mm | 17.64 mm | 15.42 mm | 18.89 mm | 12.19 mm | |
Cash remaining | 2.87 mm | 13.07 mm | 15.30 mm | 11.83 mm | 18.53 mm | |
Runway (months of cash) | 0.3 | 2.1 | 2.8 | 1.8 | 4.3 |
13F holders | Current |
---|---|
Total holders | 68 |
Opened positions | 31 |
Closed positions | 20 |
Increased positions | 6 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 104.59 bn |
Total shares | 75.42 mm |
Total puts | 33.50 k |
Total calls | 36.90 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Flagship Pioneering | 29.23 mm | $60.50 bn |
Flagship Ventures Fund V | 22.24 mm | $128.55 mm |
FMR | 6.24 mm | $12.92 bn |
Harbourvest Partners | 3.51 mm | $7.27 bn |
HarbourVest Partners | 2.65 mm | $29.99 mm |
State Of Wisconsin Investment Board | 1.86 mm | $3.84 bn |
Artal | 1.32 mm | $2.74 bn |
Vanguard | 1.11 mm | $2.31 bn |
Blue Owl Capital | 1.06 mm | $2.19 bn |
Citadel Advisors | 1.03 mm | $2.14 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Dec 24 | Ravi Mehrotra | Stock Option Common Stock | Grant | Acquire A | No | No | 0.949 | 50,000 | 47.45 k | 50,000 |
22 Nov 24 | Jennifer Ann Nelson | Stock Option Common Stock | Grant | Acquire A | No | No | 0.786 | 110,000 | 86.46 k | 110,000 |
15 Nov 24 | Kaan Certel | Stock Option Common Stock | Grant | Acquire A | No | No | 0.8284 | 340,000 | 281.66 k | 340,000 |
2 Oct 24 | Robert L. Rosiello | Stock Option Common Stock | Grant | Acquire A | No | No | 1.09 | 50,000 | 54.50 k | 50,000 |